1-3 of 3
Dominic T Moore, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Efficacy and Safety of VP-16 and G-CSF as a Mobilization Regimen Prior to Autologous Stem Cell Transplantation (ASCT) for Patients (Pts) with Multiple Myeloma (MM) and Lymphoma.

William A. Wood, MD, MPH, Julia Whitley, Dominic T Moore, PhD, Jonathan S Serody, MD, Don A. Gabriel, MD, PhD, James M. Coghill, MD, Robert Irons, PA-C, Thomas C. Shea, MD
Journal: Blood
Blood (2009) 114 (22): 4225.
https://doi.org/10.1182/blood.V114.22.4225.4225
Published: 2009
Journal Articles

Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study.

Peter M. Voorhees, MD, Cristina Gasparetto, MD, Kristy L. Richards, PhD, MD, Reynaldo Garcia, RN, OCN, John S. Strader, Madlyn Ferraro, RN, OCN, CCRC, Jennifer MacLean, RN, Diane Winans, Dominic T. Moore, PhD, Andrew Dodd, Matthew C. Foster, MD, Don A. Gabriel, MD, PhD, Thomas C. Shea, Jonathan Serody, MD, Hendrik W. van Deventer, MD, Syed Rizvi, Robert Z. Orlowski, M.D., Ph.D., David D. Hurd, MD
Journal: Blood
Blood (2009) 114 (22): 306.
https://doi.org/10.1182/blood.V114.22.306.306
Published: 2009
Journal Articles

A Phase I Study of Bortezomib (Velcade ® ) Plus 90 yttrium Labeled Ibritumomab Tiuxetan (Zevalin ® ) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (NHL)

Anne Beaven, MD, Thomas C. Shea, MD, Dominic T Moore, PhD, Tatyana Feldman, MD, Anastasia Ivanova, PhD, Madlyn Ferraro, RN, OCN, CCRC, Peggy Ford, RN, Judy Smith, RN, Andre Goy, MD
Journal: Blood
Blood (2008) 112 (11): 4944.
https://doi.org/10.1182/blood.V112.11.4944.4944
Published: 2008